<DOC>
	<DOC>NCT01519726</DOC>
	<brief_summary>Before and during bariatric surgery patients are given oral and i.v. midazolam, respectively and blood samples are drawn to establish midazolam time-concentration profiles. After 0.5-2 years, and substantial weight loss, oral and i.v. midazolam are administered once more and blood samples are taken again.</brief_summary>
	<brief_title>CYP3A4 Metabolism Before and After Surgery Induced Weight Loss Using Midazolam as Model Drug</brief_title>
	<detailed_description />
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Obesity, Morbid</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>BMI&gt;40 undergoing bariatric surgery use of drug inducing or inhibiting CYP3A4 activity pregnancy, breastfeeding renl insufficiency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>